Ketamine for depression in intensive care patients
Treatments studied
Part of Mental health clinical trials.
This study tests whether low-dose ketamine infusions can reduce depressive symptoms in patients staying in the intensive care unit for at least 6 days. Ketamine is a medication that may work differently than standard antidepressants and could provide faster relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–99 years old and have been in the ICU for 6 or more days
- You have moderate to severe depression symptoms (PHQ-9 score of 10 or higher)
- You can understand and agree to participate in the study
- You are medically stable (normal oxygen, blood pressure, heart rate, and breathing rate)
- You weigh between 45 kg and 115 kg (roughly 99–253 pounds)
- You do not have a history of psychosis, hallucinations, dementia, or certain psychiatric conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a single low dose of ketamine (a medication that can lift mood) affects brain electrical activity in people who are already having brain electrodes placed for epilepsy monitoring. If you have mild depression symptoms, you might benefit from this research.
This study tests whether ketamine, a sedative and painkiller, works better than usual sedatives in ICU patients who need help breathing. If you qualify, taking part may help reduce the amount of other sedatives you need.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.